BioEclipse Therapeutics Funding & Investors

BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology.

Total Amount Raised: $15,699,689

BioEclipse Therapeutics Funding Rounds

Grant
$7,999,689
Apr 25, 2022
Grant Investors
California Institute for Regenerative Medicine
Series A
$7,700,000
Jun 23, 2019
Series A Investors
Revelis Capital Group
TSVC
Foothill Ventures
Plum Alley Investments
DEFTA Partners

Funding info provided by Diffbot.